Management of coagulopathy with recombinant factor VIIa in a neonate with echovirus type 7

Pediatric Blood and Cancer

Volumn 43, Issue 2, 2004, Pages 170-176

  Tancabelic, Jakica ^a   Haun, Steven Edward ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Coagulopathy; Echovirus type 7; Recombinant factor VIIa

Indexed keywords

ACICLOVIR; AMPICILLIN; BUMETANIDE; CEFOTAXIME; FRESH FROZEN PLASMA; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; OXYGEN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; BLOOD CLOTTING DISORDER; BODY WEIGHT; BRAIN HEMORRHAGE; BRAIN VENTRICLE HEMORRHAGE; CASE REPORT; CATHETERIZATION; CONTINUOUS INFUSION; CRYOPRECIPITATE; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE CALCULATION; ECHO VIRUS; ECHO VIRUS 7; ENTEROVIRUS; FLUID THERAPY; HEMOSTASIS; HUMAN; HYPERTENSION; INFECTION COMPLICATION; KIDNEY FAILURE; KLEBSIELLA PNEUMONIAE; LIVER DYSFUNCTION; MALE; NEWBORN; NEWBORN DISEASE; PRIORITY JOURNAL; PROCESS MONITORING; RESPIRATORY FAILURE; SEPSIS; STATISTICAL SIGNIFICANCE; THROMBOSIS; VIRUS INFECTION;

BLOOD COAGULATION DISORDERS; DISSEMINATED INTRAVASCULAR COAGULATION; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; FACTOR VIIA; HUMANS; INFANT, NEWBORN; INTRACRANIAL HEMORRHAGES; MALE; RECOMBINANT PROTEINS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 3042836547     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20078     Document Type: Article

References (21)

1. Ho-Yen DO, Hardie R, McClure J, et al. Fatal outcome of echovirus 7 infection. Scand J Infect Dis 1989;21:459-461.
2. Ventura KC, Hawkins H, Smith MB, et al. Fatal neonatal echovirus 6 infections: Autopsy case report and review of the literature. Mod Pathol 2001;14(2):85-90.
3. Amon R, Naor N, Davidson S, et al. Fatal outcome of neonatal echovirus 19 infection. Pediatr Infect Dis J 1991;10(10):788-789.
4. Chambon M, Delage C, Bailly JL, et al. Fatal hepatic necrosis in a neonate with echovirus 20 infection: Use of the polymerase chain reaction to detect enterovirus in liver tissue. Clin Infect Dis 1997;24:523-524.
5. Wang J, Atchison RW, Walpusk J, et al. Echovirus hepatic failure in Infancy: Report of four cases with speculation on the pathogenesis. Pediatr Develop Pathol 2001;4:454-460.
6. Mostoufizadeh MG, Lack EL, Gang DL, et al. Postmortem manifestation of echovirus sepsis in five newborn infants. Hum Pathol 1983;14(9):818-823.
7. Esmon CT. Blood Coagulation. In: Nathan DG, Orkin SH, Ginsburg D, Look TA, editors. Nathan and Oski's Hematology of Infancy and Childhood, 6th edition. Philadelphia, PA: WW Saunders Company, 2003. pp 1486-1487.
8. Gerotziafas GT, Zervas K, Arzoglou P, et al. On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life threatening haemorrhage: Focus on prothrombin activation. Br J Hematol 2002;117:705-708.
9. Bernstein DE, Jeffers L, Erhardsten E, et al. Recombinant factor VII corrects prothrombin time in cirrhotic patients: A preliminary study. Gastroenterology 1997;113:1930-1937.
10. Puetz JJ, Bouhasin JD. Use of recombinant factor VIIa to control bleeding in an adolescent male with severe hemophilia A, HIV, thrombocytopenia, hepatitis C, and end stage liver disease. Am J Hops Palliate Care 2002;19(4):277-282.
11. Hoffman M, Monroe DM, Roberts HR. Activated factor VII activates factors IX and X on the surface of activated platelets: Thoughts on the mechanism of action of high dose activated factor VII. Blood Coagul Fibrinolysis 1998;1(Suppl):S61-S65.
12. Kjalke M, Ezban M, Monroe DM, et al. High dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia like conditions in a cell based model system. Br J Haematol 2001;114(1):114-120.
13. Hoffman M, Monroe DM. The action of high dose factor VIIa (FVIIa) in a cell based model of hemostasis. Dis Mon 2003;49(1): 14-21.
14. Veldman A, Fischer D, Virgo B, et al. Life threatening hemorrhage in neonates: Management with recombinant activated factor VII. Intensive Care Med 2002;28:1635-1637.
15. Chuansumrit A, Nuntnarumit P, Okascharoen C, et al. The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy, Pediatrics 2002;107: 169-171.
16. Young G, Nugent DJ. Prevention of bleeding complications in neonates with liver failure undergoing surgery using recombinant factor VIIa. Hematology 2001;6:341-346.
17. Chuansumrit A, Chantarojanasiri P, Isarangkura P, et al. Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2000;11(Suppl):S101-S105.
18. Tobias JD, Berkenbosch JW, Russo P. Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. Pediatr Crit Care Med 2003;4:49-51.
19. The ACCP/CCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-1655.
20. Hayden WR. Sepsis terminology in pediatrics. J Pediatr 1994; 124(4):657-658.
21. Ueno H, Hirasawa H, Oda S, et al. Coagulation/fibrinolysis abnormality and vascular endothelial damage in the pathogenesis of thrombocytopenic multiple organ failure. Crit Care Med 2002; 30(10):2242-2248.